发明公开
- 专利标题: DELAYED RELEASE FORMULATIONS OF 6-MERCAPTOPURINE
- 专利标题(中): 制剂6-巯基嘌呤延迟释放
-
申请号: EP05767572.0申请日: 2005-04-01
-
公开(公告)号: EP1746975A2公开(公告)日: 2007-01-31
- 发明人: LERNER, Itzhak, E. , FLASHNER-BARAK, Moshe , ACHTHOVEN, Erwin v , KEEGSTRA, Hans , SMIT, Ruud
- 申请人: Teva Pharmaceutical Industries Limited
- 申请人地址: 5 Basel Street, Box 3190 Petah Tikvah 49131 IL
- 专利权人: Teva Pharmaceutical Industries Limited
- 当前专利权人: Teva Pharmaceutical Industries Limited
- 当前专利权人地址: 5 Basel Street, Box 3190 Petah Tikvah 49131 IL
- 代理机构: Russell, Tim
- 优先权: US558477P 20040401
- 国际公布: WO2005099666 20051027
- 主分类号: A61K9/00
- IPC分类号: A61K9/00
摘要:
The present invention provides enteric ally coated formulations of 6-mercaptopurine that exhibit a delay in release of the 6-mercaptopurine such that substantial release of 6-mercaptopurine does not occur until after passage through the stomach. Optionally, the formulations also comprise a delay coating in addition to the enteric coating that provides an even further delay such that substantial release of 6-mercaptopurine does not occur until after a certain period of time following passage through the stomach. Such a period of time is preferably at least one hour after passage through the stomach. Following the delay imparted by the enteric coating and optional delay coating, the formulations exhibit better bioavailability and faster dissolution than previous formulations.
信息查询